• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Neurogene Inc. - Common Stock (NQ: NGNE )

    34.52 -4.69 (-11.95%)
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 15, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Headline News about Neurogene Inc. - Common Stock

    Earnings Scheduled For November 15, 2024
    Via Benzinga
    Neurogene Stock Plummets 44%: Is All Hope Lost for This Biotech?"
    Neurogene has been on a huge run in 2024. That came to a halt after the company released trial results. But, the results may be better than the market thinks. 
    Via MarketBeat
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    Dow Dips Over 200 Points; Home Depot Posts Upbeat Earnings
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Neurogene Stock Tanks After Adverse Event In Early-Stage Rett Syndrome Gene Therapy Trial
    Neurogene reports interim Phase 1/2 trial results for NGN-401 gene therapy in treating pediatric Rett syndrome, showing improved safety and efficacy. 
    Via Benzinga
    MicroMarvel Neurogene Challenges Big Pharma
    Neurogene Inc. develops life-changing genetic medicines for patients and their families affected by neurological diseases. 
    Via Talk Markets
    Top 1% Biotech Neurogene Crashes, Wiping Out A Run, On A Serious Side Effect
    Neurogene tested its gene therapy in female patients with Rett syndrome. 
    Via Investor's Business Daily
    Why Grab Holdings Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    S&P 500 Edges Lower; Yum China Earnings Top Views
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Crude Oil Gains 3%; Constellation Energy Shares Tumble After Q3 Results
    Via Benzinga
    Exposures Fossil Fuels
    Integra LifeSciences Posts Upbeat Results, Joins Air Transport Services, Freshpet, Yum China And Other Big Stocks Moving Higher On Monday
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    NGNE Stock Earnings: Neurogene Misses EPS for Q2 2024
    NGNE stock results show that Neurogene missed analyst estimates for earnings per share the second quarter of 2024. 
    Via InvestorPlace
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    Why Quantum Shares Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    NGNE Stock Earnings: Neurogene Beats EPS for Q1 2024
    NGNE stock results show that Neurogene beat analyst estimates for earnings per share the first quarter of 2024. 
    Via InvestorPlace
    7 A-Rated Aggressive Biotech Stocks to Bet On in 2024
    We’re using the Portfolio Grader to find the best biotech stocks to buy in today’s market. Each of these stocks get top grades. 
    Via InvestorPlace
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.